Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Taking on the market leader

May 4, 2005 Sales and Marketing

Launching a new product into a therapeutic area dominated by a 'gold standard' doctors' favourite is a tough task but …
Feature

Velcade moves up to second line treatment

April 28, 2005 Sales and Marketing

Ortho Biotech's Velcade has received approval as a second-line treatment for patients with multiple myeloma in Europe, advancing it from …
News

EMEA advises against prescribing of antidepressants in children

April 28, 2005 Sales and Marketing

Doctors across Europe will be discouraged from prescribing most modern antidepressants for children and adolescents following new EMEA advice.Investigations into …
News

Cholesterol drugs boost Schering-Plough

April 26, 2005 Sales and Marketing

News

Strattera sales fall back over continuing safety concerns

April 26, 2005 Sales and Marketing

Lilly say it expects sales of Strattera to fall in 2005 because of continuing concerns over the safety of ADHD …
News

MHRA failing patients, warns report

April 26, 2005 Sales and Marketing

MPs have called for an urgent review of the UK drugs regulator, saying that tougher regulation of the industry is …
News

Bextra withdrawal dents Pfizer’s sales juggernaut

April 22, 2005 Sales and Marketing

The suspension and withdrawal of Pfizer's Cox-II inhibitor Bextra has forced the company to cut its profit forecast for 2005, …
News

US court rules in favour of Lilly’s Zyprexa

April 18, 2005 Sales and Marketing

Lilly's US patent on blockbuster antipsychotic drug Zyprexa (olanzapine) has been upheld, after a Supreme Court ruled against its generic …
News

Japanese companies merge to form Astellas

April 13, 2005 Sales and Marketing

News

Eloxatin and Campto gain new NICE approval

April 13, 2005 Sales and Marketing

NICE has recommended two more chemotherapy drugs for the first-line treatment of advanced colorectal cancer.The institute said that Sanofi-Aventis' Eloxatin …
News

Secrets of a youthful brand

April 12, 2005 Sales and Marketing Pan Advertising, Teva, lilly

 Today, more than ever before, the pharmaceutical industry is constantly being reminded that a blockbuster drug’s days are numbered and …
Feature

New depression treatment relieves sleep problems in patients

April 12, 2005 Sales and Marketing

An innovative new depression drug has shown improved benefits over existing treatments, according to data presented by its manufacturer Servier.Valdoxan …
News

Serono hit by two late-stage failures

April 8, 2005 Research and Development, Sales and Marketing

Serono has halted development of a late-stage psoriasis drug and stopped another trial for a new skin cancer drug.Both drugs …
News

Bextra suspended from European and US markets

April 8, 2005 Sales and Marketing

News

No salesforce purge in Pfizer’s $4 billion cuts

April 7, 2005 Sales and Marketing

Pfizer has set out a $4 billion cost cutting programme for the next three years in an attempt to return …
News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026